← Back to Search

Neurotypical adults for Parkinson's Disease

N/A
Recruiting
Led By Gregory Wallace, PhD
Research Sponsored by Gregory Wallace
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

Study Summary

Adults with Parkinson's Disease experience an array of challenges and changes in daily living, behaviors, and functioning throughout the progression of their condition. The investigators want to learn more about the effects of Parkinson's Disease on individuals' social behavior and quality of life (QoL) compared to people of the same age without Parkinson's Disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Activities of Daily Living
Cognition
Mental Health
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Parkinson's diseaseExperimental Treatment1 Intervention
This group includes adults who: Have been diagnosed with Parkinsons Disease by a healthcare professional Are at least 40 years old and Do not possess a diagnosis of autism or any other developmental disability (e.g., Down syndrome)
Group II: Neurotypical adultsExperimental Treatment1 Intervention
This group includes adults who: Are at least 40 years old Do not have a diagnosis of Parkinsons Disease or any form of dementia and Do not have a diagnosis of autism or any other developmental disability (e.g., Down syndrome)

Find a Location

Who is running the clinical trial?

Gregory WallaceLead Sponsor
Gregory Wallace, PhDPrincipal InvestigatorGeorge Washington University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Social & QoL Behaviors in Parkinson's Disease
Gregory Wallace 2024. "Social & QoL Behaviors in Parkinson's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06385184.
All > Paid Studies Baltimore
~333 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top